| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |